 | Up a level |
Feakins, Roger; Borralho Nunes, Paulo; Driessen, Ann; Gordon, Ilyssa O; Zidar, Nina; Baldin, Pamela; Christensen, Britt; Danese, Silvio; Herlihy, Naoimh; Iacucci, Marietta; Loughrey, Maurice B; Magro, Fernando; Mookhoek, Aart; Svrcek, Magali; Rosini, Francesca (2024). Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper. Journal of Crohn's & colitis, 18(2), pp. 175-191. Oxford University Press 10.1093/ecco-jcc/jjad142
Danese, Silvio; Vermeire, Séverine; Zhou, Wen; Pangan, Aileen L; Siffledeen, Jesse; Greenbloom, Susan; Hébuterne, Xavier; D'Haens, Geert; Nakase, Hiroshi; Panés, Julian; Higgins, Peter D R; Juillerat, Pascal; Lindsay, James O; Loftus, Edward V; Sandborn, William J; Reinisch, Walter; Chen, Min-Hu; Sanchez Gonzalez, Yuri; Huang, Bidan; Xie, Wangang; ... (2022). Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. The lancet, 399(10341), pp. 2113-2128. Elsevier 10.1016/S0140-6736(22)00581-5
Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan (2022). Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. The lancet. Gastroenterology & hepatology, 7(2), pp. 118-127. Elsevier 10.1016/S2468-1253(21)00294-6
Lang-Schwarz, Corinna; Angeloni, Miriam; Agaimy, Abbas; Atreya, Raja; Becker, Christoph; Dregelies, Theresa; Danese, Silvio; Fléjou, Jean-François; Gaßler, Nikolaus; Grabsch, Heike I; Hartmann, Arndt; Kamarádová, Kateřina; Kühl, Anja A; Lauwers, Gregory Y; Lugli, Alessandro; Nagtegaal, Iris; Neurath, Markus F; Oberhuber, Georg; Peyrin-Biroulet, Laurent; Rath, Timo; ... (2021). Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease. Journal of Crohn's & colitis, 15(10), pp. 1621-1630. Oxford University Press 10.1093/ecco-jcc/jjab055
Lang-Schwarz, Corinna; Agaimy, Abbas; Atreya, Raja; Becker, Christoph; Danese, Silvio; Fléjou, Jean-François; Gaßler, Nikolaus; Grabsch, Heike I.; Hartmann, Arndt; Kamarádová, Kateřina; Kühl, Anja A.; Lauwers, Gregory Y.; Lugli, Alessandro; Nagtegaal, Iris; Neurath, Markus F.; Oberhuber, Georg; Peyrin-Biroulet, Laurent; Rath, Timo; Riddell, Robert; Rubio, Carlos A.; ... (2021). Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn’s disease. Virchows Archiv, 478(3), pp. 581-594. Springer 10.1007/s00428-020-02982-7
Niess, Jan Hendrik; Danese, Silvio (2014). Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology? Gut, 63(4), pp. 533-535. BMJ Publishing Group 10.1136/gutjnl-2013-304683
Deban, Livija; Russo, Remo Castro; Sironi, Marina; Moalli, Federica; Scanziani, Margherita; Zambelli, Vanessa; Cuccovillo, Ivan; Bastone, Antonio; Gobbi, Marco; Valentino, Sonia; Doni, Andrea; Garlanda, Cecilia; Danese, Silvio; Salvatori, Giovanni; Sassano, Marica; Evangelista, Virgilio; Rossi, Barbara; Zenaro, Elena; Constantin, Gabriela; Laudanna, Carlo; ... (2010). Regulation of leukocyte recruitment by the long pentraxin PTX3. Nature immunology, 11(4), pp. 328-34. New York, N.Y.: Nature Publishing Group 10.1038/ni.1854
